Home » Stocks » CRXM

Gene Biotherapeutics Inc. (CRXM)

Stock Price: $0.0510 USD 0.0110 (27.50%)
Updated Feb 26, 2021 10:38 AM EST - Market open
Market Cap 1.49M
Revenue (ttm) n/a
Net Income (ttm) -3.85M
Shares Out 14.05M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $0.0510
Previous Close $0.0400
Change ($) 0.0110
Change (%) 27.50%
Day's Open 0.0485
Day's Range 0.0450 - 0.0510
Day's Volume 810,367
52-Week Range 0.0204 - 0.17

News

There are no news available yet.

About CRXM

Gene Biotherapeutics manages a portfolio of medical technologies in the United States. It focuses on acquiring and developing gene-based therapeutics. The company, through its subsidiary, Angionetics, Inc., focuses on the clinical advancement and commercialization of Generx, an interventional cardiology, angiogenic gene therapy Phase 3 product candidate designed for the potential treatment of patients with refractory angina due to advanced coronary artery disease. It also holds royalties on the commercialization of Excellagen technology platfor... [Read more...]

Industry
Biotechnology
Founded
2003
CEO
Christopher Reinhard
Employees
6
Stock Exchange
OTCMKTS
Ticker Symbol
CRXM
Full Company Profile

Financial Performance

Financial Statements